Literature DB >> 9112456

Complications following definitive irradiation for cancers of the oral cavity and the oropharynx (in a series of 1134 patients).

M Pernot1, E Luporsi, S Hoffstetter, D Peiffert, P Aletti, C Marchal, P Kozminski, A Noël, P Bey.   

Abstract

PURPOSE: To study the rate and severity of complications in a series of 1134 patients treated by definitive irradiation for tumors of the oral cavity (772 cases) or the oropharynx (361 cases). METHODS AND MATERIALS: Patients were staged as 29.5% T1, 42% T2, 26% T3, 2.5% T4-Tx, and 74.5% N0 tumors. We treated 364 patients with brachytherapy only (192Ir) for the primary lesion. External irradiation and brachytherapy were combined for 770 patients.
RESULTS: The results included local control and survival. Out of 1134 patients, 330 had 376 complications. Grade 1 complications occurred in 20% of the patients, Grade 2 in 9%; Grade 3 in 4%; and Grade 4 in 0.2%. Of the Grade 1 complications, 78% were soft tissue and only 24% were bone complications. For the more severe grades (2, 3, and 4), there were 56 soft tissue complications and 90 bone complications out of 1340 patients. The statistical analysis included tumor-related factors and treatment-related factors. For the first two factors, only tumor location was significant. The treatment-related factors significant for complications were studied in univariate and multivariate study. This multivariate study confirmed that for soft tissue complications dose rate and volume treated were important (p < 0.001). It also confirmed that for bone complications, total dose > 80 Gy, dose rate > 0.7 Gy/h, and the absence of leaded protection of the mandible were all important factors.
CONCLUSION: This statistical study should allow future reduction of severe complications (Grades 2, 3, 4), if treatment factors inducing them can be taken into account. This is not always possible for very large tumors.

Entities:  

Mesh:

Year:  1997        PMID: 9112456     DOI: 10.1016/s0360-3016(96)00612-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.

Authors:  Douglas E Peterson; Wolfgang Doerr; Allan Hovan; Andres Pinto; Debbie Saunders; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-06-06       Impact factor: 3.603

2.  Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.

Authors:  N Gopalakrishna Iyer; Snjezana Dogan; Frank Palmer; Rahmatullah Rahmati; Iain J Nixon; Nancy Lee; Snehal G Patel; Jatin P Shah; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-03-24       Impact factor: 5.344

3.  Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines.

Authors:  Rajendra Bhalavat; Ashwini Budrukkar; Sarbani Ghosh Laskar; Dayanand Sharma; Ashutosh Mukherji; Manish Chandra; Umesh Mahantshetty; Vibhay Pareek; Pratibha Bauskar; Sonali Saraf
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

4.  Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.

Authors:  Marina Kimie Oba; Lara Maria Alencar Ramos Innocentini; Gustavo Viani; Hilton Marcos Alves Ricz; Thiago de Carvalho Reis; Tatiane Cristina Ferrari; Leandro Dorigan de Macedo
Journal:  Support Care Cancer       Date:  2020-04-21       Impact factor: 3.603

Review 5.  Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.

Authors:  György Kovács
Journal:  J Contemp Brachytherapy       Date:  2014-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.